PharmExec Blog

Lilly’s ImClone Makes NYC Its Home Base

Yet another pharma firm is going to be calling New York City home. Late last month, Lilly announced that it would lease space at the Alexandria Center, to house the new research headquarters for ImClone Systems. ImClone will be the anchor tenant at Alexandria’s newest life science destination located in Manhattan’s East Side life science/medical corridor, according to a release. Alexandria Real Estate Equities was nice enough to send Pharm Exec a photo of what the site will look like. Expect it to be completed by 2010.

“New York City has always been at the forefront of scientific innovation, but the City has never fully capitalized on its assets to create a thriving commercial bioscience industry and the jobs that come with it,” stated Mayor Michael Bloomberg. “We joined with Alexandria Real Estate Equities to create the East River Science Park to provide today’s bioscience companies with the state-of-the-art commercial lab space they need to locate and expand.  Lilly’s decision to become its anchor tenant is evidence that our work is paying off.  It also serves as a major boost to our efforts to diversify New York City’s economy.”

Reblog this post [with Zemanta]
This entry was posted in Strategy and tagged , , , , , , . Bookmark the permalink. Trackbacks are closed, but you can post a comment.

One Comment

  1. Posted March 21, 2011 at 11:34 pm | Permalink

    Wow, if this happens to the United States then I’m sure my land for sale in pa would also do.

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

  • Categories

  • Meta